These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21465655)

  • 1. Nutritional phases in Prader-Willi syndrome.
    Miller JL; Lynn CH; Driscoll DC; Goldstone AP; Gold JA; Kimonis V; Dykens E; Butler MG; Shuster JJ; Driscoll DJ
    Am J Med Genet A; 2011 May; 155A(5):1040-9. PubMed ID: 21465655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.
    Kweh FA; Miller JL; Sulsona CR; Wasserfall C; Atkinson M; Shuster JJ; Goldstone AP; Driscoll DJ
    Am J Med Genet A; 2015 Jan; 167A(1):69-79. PubMed ID: 25355237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader-Willi syndrome.
    Kweh FA; Sulsona CR; Miller JL; Driscoll DJ
    Obes Sci Pract; 2023 Aug; 9(4):383-394. PubMed ID: 37546289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional phases of Prader-Willi syndrome.
    Bravo J P; Pérez P D; Canals Cifuentes A
    Andes Pediatr; 2021 Jun; 92(3):359-366. PubMed ID: 34479241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.
    Erhardt É; Molnár D
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in acylated versus unacylated ghrelin levels may be involved in the underlying mechanisms of the switch in nutritional phases in Prader-Willi syndrome.
    Grootjen LN; Diene G; Molinas C; Beauloye V; Huisman TM; Visser JA; Delhanty PJD; Kerkhof GF; Tauber M; Hokken-Koelega ACS
    Horm Res Paediatr; 2023 Oct; 97(4):343-52. PubMed ID: 37839403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
    Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
    Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Trials for Hyperphagia and Food-Related Behaviors in Prader-Willi Syndrome.
    Miller JL; Strong TV; Heinemann J
    Diseases; 2015 Jun; 3(2):78-85. PubMed ID: 28943610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood.
    Butler JV; Whittington JE; Holland AJ; McAllister CJ; Goldstone AP
    Dev Med Child Neurol; 2010 Jun; 52(6):e88-93. PubMed ID: 20041936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome.
    Beauloye V; Diene G; Kuppens R; Zech F; Winandy C; Molinas C; Faye S; Kieffer I; Beckers D; Nergårdh R; Hauffa B; Derycke C; Delhanty P; Hokken-Koelega A; Tauber M
    Orphanet J Rare Dis; 2016 May; 11(1):56. PubMed ID: 27146407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
    Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
    Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
    Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity management in Prader-Willi syndrome: current perspectives.
    Crinò A; Fintini D; Bocchini S; Grugni G
    Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.